Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cees G M Kallenberg

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Clinical and Experimental Rheumatology|October 13, 2015
Pathogenesis and treatment of ANCA-associated vasculitidesCees G M Kallenberg
Annals of the Rheumatic Diseases|December 21, 2012
Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?Cees G M Kallenberg
Current Opinion in Rheumatology|December 20, 2012
Etiopathogenesis of systemic autoimmune diseasesCees G M Kallenberg
Nature Reviews. Rheumatology|July 2, 2014
Key advances in the clinical approach to ANCA-associated vasculitisCees G M Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Pro: Cyclophosphamide in lupus nephritisCees G M Kallenberg
Current Opinion in Rheumatology|February 25, 2011
What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides?Cees G M Kallenberg
Clinical Reviews in Allergy & Immunology|January 4, 2008
The last classification of vasculitisCees G M Kallenberg
Current Opinion in Rheumatology|November 25, 2015
Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitisCees G M Kallenberg
Autoimmunity Reviews|July 9, 2008
Anti-C1q autoantibodiesCees G M Kallenberg
Arthritis and Rheumatism|September 6, 2005
Churg-Strauss syndrome: just one disease entity?Cees G M Kallenberg
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Clinical and Experimental Rheumatology|October 13, 2015
Pathogenesis and treatment of ANCA-associated vasculitidesCees G M Kallenberg
Annals of the Rheumatic Diseases|December 21, 2012
Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?Cees G M Kallenberg
Current Opinion in Rheumatology|December 20, 2012
Etiopathogenesis of systemic autoimmune diseasesCees G M Kallenberg
Nature Reviews. Rheumatology|July 2, 2014
Key advances in the clinical approach to ANCA-associated vasculitisCees G M Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Pro: Cyclophosphamide in lupus nephritisCees G M Kallenberg
Current Opinion in Rheumatology|February 25, 2011
What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides?Cees G M Kallenberg
Clinical Reviews in Allergy & Immunology|January 4, 2008
The last classification of vasculitisCees G M Kallenberg
Current Opinion in Rheumatology|November 25, 2015
Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitisCees G M Kallenberg
Autoimmunity Reviews|July 9, 2008
Anti-C1q autoantibodiesCees G M Kallenberg
Arthritis and Rheumatism|September 6, 2005
Churg-Strauss syndrome: just one disease entity?Cees G M Kallenberg
Pageof 22